Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.

Akiyama H, Nishida Y, Chang KH, Bedoy AD, Muftuoglu M, Ma W, Basyal M, Hirschi Z, Honma D, Tsutsumi S, Wang J, Zhang W, Huang X, Rampal RK, Oluwole OO, Bixby DL, Daver NG, Andreeff M

Open source

DOI: 10.1038/s41408-025-01266-0
Published: 2025 Apr 24
Container: Blood cancer journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41408-025-01266-0,
  title = {Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.},
  author = {Akiyama H and Nishida Y and Chang KH and Bedoy AD and Muftuoglu M and Ma W and Basyal M and Hirschi Z and Honma D and Tsutsumi S and Wang J and Zhang W and Huang X and Rampal RK and Oluwole OO and Bixby DL and Daver NG and Andreeff M},
  year = {2025},
  journal = {Blood cancer journal},
  doi = {10.1038/s41408-025-01266-0},
  url = {https://doi.org/10.1038/s41408-025-01266-0}
}

RIS

TY  - JOUR
TI  - Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.
AU  - Akiyama H
AU  - Nishida Y
AU  - Chang KH
AU  - Bedoy AD
AU  - Muftuoglu M
AU  - Ma W
AU  - Basyal M
AU  - Hirschi Z
AU  - Honma D
AU  - Tsutsumi S
AU  - Wang J
AU  - Zhang W
AU  - Huang X
AU  - Rampal RK
AU  - Oluwole OO
AU  - Bixby DL
AU  - Daver NG
AU  - Andreeff M
PY  - 2025
JO  - Blood cancer journal
DO  - 10.1038/s41408-025-01266-0
UR  - https://doi.org/10.1038/s41408-025-01266-0
ER  -

APA

H, A., Y, N., KH, C., AD, B., M, M., W, M., M, B., Z, H., D, H., S, T., J, W., W, Z., X, H., RK, R., OO, O., DL, B., NG, D., & M, A. (2025). Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia.. Blood cancer journal. https://doi.org/10.1038/s41408-025-01266-0

Source records

pubmed · retrieved 2026-09-27T14:35:49.449Z